-+ 0.00%
-+ 0.00%
-+ 0.00%

China Pharma Delays Third-Quarter Report, Targets Nov. 23 Filing

PUBT·11/17/2026 19:46:13
Listen to the news
China Pharma Delays Third-Quarter Report, Targets Nov. 23 Filing
  • China Pharma Holdings delayed its Form 10-Q for the quarter ended September 30, 2026, targeting filing by November 23, 2026.
  • Compiling, distributing and reviewing financial information created time constraints that made timely filing impracticable without undue hardship and expense.
  • Preliminary revenue rose to approximately $1.15 million from $760,000 a year earlier.
  • Operating loss widened to approximately $1.88 million from $630,000 a year earlier.
  • Net loss increased to approximately $1.9 million from $650,000 a year earlier.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Pharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-121329), on November 17, 2026, and is solely responsible for the information contained therein.